Scientific Publications  

Med Discovery announces executive R&D promotion

2010-12-20, Med Discovery appoints Christoph Kündig as Chief Scientific Officer

Christoph Kündig served as the company’s director of R&D since the beginning of its R&D activity heading Med Discovery’s drug discovery, early preclinical and CMC operations. As CSO Dr. Kündig will manage the transition of Med Discovery’s lead projects from preclinical into early clinical development.